Stocks · Health care · Pharmaceutical Preparations

MADRIGAL PHARMACEUTICALS, INC.

MDGL Clue Score55
United States Fiscal year ends December CIK 0001157601 Results filed 3 Nov 2026

What the insiders did No buying or selling

By person

17 insiders · 0 transactions
117×

Bill Sibold holds 117 times base salary in stock. $108.04M of shares against $918.53K in salary for 2025.

Salary from the company's own proxy. The shares are what Bill Sibold last reported holding, valued at $546.38, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Baker Bros. Advisors LP entity
Director
—
—
—
1,948,876
$1.06B
+9.6%
Rebecca Taub
Director
—
—
—
452,667
$247.33M
−1.4%
Fred B Craves
Director
—
—
—
361,076
$197.28M
−1.9%
William John Sibold
President and CEO
—
—
—
197,746
$108.04M
+253.8%
Paul A Friedman
Director
—
—
—
187,164
$102.26M
+0.4%
Richard S Levy
Director
—
—
—
22,469
$12.28M
+104.0%
Carole Huntsman
Chief Commercial Officer
—
—
—
12,692
$6.93M
+10.6%
Mardi Dier
EVP and CFO
—
—
—
12,490
$6.82M
+40.7%
Shannon T Kelley
General Counsel
—
—
—
11,474
$6.27M
+43.7%
David Soergel
Chief Medical Officer
—
—
—
10,033
$5.48M
—
Robert E. Waltermire
Senior VP, Chief Pharma Dev.
—
—
—
5,789
$3.16M
+5.3%
James M Daly
Director
—
—
—
3,081
$1.68M
+61.1%
Kenneth Bate
Director
—
—
—
2,627
$1.44M
+37.4%
Rita Thakkar
Chief Accounting Officer
—
—
—
2,398
$1.31M
—
Jacqualyn A Fouse
Director
—
—
—
1,551
$847.43K
—
Daniel J. Brennan
Director
—
—
—
1,371
$749.08K
—
John C Reed
Director
—
—
—
647
$353.51K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.